| Related Articles |
Fixed drug eruption related to sunitinib: a case report.
Dermatol Online J. 2018 Jun 15;24(6):
Authors: Bhatia A, Jha N, Kanish B
Abstract
Sunitinib is an oral multi-targeted tyrosine kinase inhibitor. It has been approved for the treatment of gastro-intestinal stromal tumor and advanced renal cell carcinoma. Fixed drug eruption related to sunitinib is a rare cutaneous adverse drug reaction.
PMID: 30142719 [PubMed - indexed for MEDLINE]
from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2C7VjhQ
No comments:
Post a Comment